Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
0.341
-0.102 (-22.99%)
At close: Jun 26, 2026, 4:00 PM EDT
0.350
+0.009 (2.64%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Jasper Therapeutics Stock Forecast
JSPR's stock price has decreased by -93.87% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Jasper Therapeutics stock have an average target of 9.70, with a low estimate of 1.50 and a high estimate of 20. The average target predicts an increase of 2,744.57% from the current stock price of 0.34.
Analyst Consensus: Buy
* Price targets were last updated on May 15, 2026.
Analyst Ratings
The average analyst rating for Jasper Therapeutics stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 3 | 3 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Jun 1, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +779.77% | May 15, 2026 |
| TD Cowen | TD Cowen | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | May 15, 2026 |
| UBS | UBS | Hold Maintains $1.5 | Hold | Maintains | $1.5 | +339.88% | Apr 2, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $12 → $7 | Buy | Maintains | $12 → $7 | +1,952.79% | Apr 1, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.41
from -4.40
EPS Next Year
-2.56
from -2.41
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.41 | -2.56 | |
| Avg | -2.41 | -2.56 | |
| Low | -2.41 | -2.56 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.